• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Technology Bio Tech

Oneview Healthcare Shares Up Thanks to Upbeat Quarterly (ASX:ONE)

Like 0

By Ryan Clarkson-Ledward, Friday, 23 April 2021

The Digital healthcare developer Oneview Healthcare PLC [ASX:ONE] share price is up 9.46% at the time of writing. Lifting on the back of its latest quarterly result...

The Digital healthcare developer Oneview Healthcare PLC [ASX:ONE] share price is up 9.46% at the time of writing. Lifting on the back of its latest quarterly result.

Regular readers may recall this stock thanks to its recent cloud platform debut. A story that we covered here.

Because as noted at the time, this stock has surged in 2021. With today’s update showcasing and reiterating that same strong growth narrative.

Let’s take a closer look…

Growing operations, growing cash flows

As management highlights, the March quarter was a big one for Oneview.

The launch of their cloud platform was obviously huge. A world first of its kind, according to the company.

On top of that though, they tied up several new or expansion contracts during the period. Building momentum for their products and services, as well as bringing in some much-needed revenues.

Speaking of which, receipts from customers totaled €2.82 million for the quarter. A 64% increase quarter-on-quarter.

A strong sign of the growth potential of this stock, albeit from a low base.

However, Oneview also made a point of showcasing how their cash outflows are steadily falling. Bringing them closer to breakeven cash flow, and hopefully positive cash flow soon.

We reveal four little-known small-cap stocks that cannot be ignored…Download your free report now.

Here is a breakdown of their last five quarters for reference:

Quarterly Trend - Cash Out FlowSource: Oneview Healthcare

Looking ahead, if Oneview can keep growing their sales, then this trend should continue. And for investors that is exactly the kind of prognosis they will be after.

Indeed, CEO James Fitter believes there is a lot more to look forward to, commenting:

‘This has been a transformational quarter for Oneview in many ways. The Company is proud to continue to not only improve its services offering for clients but continue its commitment to innovation.

‘I’d like to thank investors for their continue support, and also the staff at Oneview for the success the Company has experienced in achieving key engineering milestones. We look forward to updating the market on further developments as we continue to improve experience, optimize patient flow and deliver virtual care solutions for our customers around the world.’

What’s next for Oneview Share Price?

Again, the focus for shareholders will certainly remain on growth. Both operationally and in terms of top-line results.

How and when Oneview will achieve this growth though is the big variable. Because depending on how fast they can capture a solid market for their software, the share price will move accordingly.

After all, as a tech player there is a certain expectation of expediated growth. A precedent that has been set by other past and present success stories.

But, Oneview certainly isn’t the only stock with this kind of opportunity. The ASX is chock-full of tech and software plays that are equally waiting to seize upon their growth potential.

We’ve even put together a list of five of our favourites in our latest report.

You can check them out, for free, right here.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Cash in thanks to billionaire Jim Rogers…NOW
    By Callum Newman

    We don’t know where Trump is taking the world. But we do know the Aussie government game plan. It’s simple… Spend! Spend! Spend! Yes, it’s our tax dollars going out, no doubt some of it due to be wasted and squandered. We can’t stop that. What we can do is own the firm(s) that might be on the receiving end. Here’s an idea…

  • Lies, Lies and GDP Statistics
    By Callum Newman

    If the second quarter comes out negative too, then the USA would be in a “technical” recession. That’s two quarters of negative GDP. Yawn! Here are two reasons why this kind of thing can be misleading when it comes to the share market.

  • Special Edition Uranium (Part III): The Western Supply Dilemma
    By James Cooper

    Former geologist James Cooper continues with his special three-part series on uranium. Today’s edition continues with uranium’s hidden vulnerabilities in the global supply chain.

Primary Sidebar

Latest Articles

  • Cash in thanks to billionaire Jim Rogers…NOW
  • Lies, Lies and GDP Statistics
  • Special Edition Uranium (Part III): The Western Supply Dilemma
  • Aussie shoppers: not as bad as you think!
  • Trade war victims: flushing out…with more to come!

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988